Industry Briefs: May 21, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.
Company News
Avalanche Biotechnologies and Lonza have formed a manufacturing collaboration focused on process development and scale-up efforts for the manufacturing of adeno-associated viral vectors for gene therapy.
GlaxoSmithKline has completed the transaction to increase its ownership in the biopharmaceutical company Theravance.
Lubrizol has formed
Marina Biotech and Girindus Group have formed a development, supply, and commercialization pact for oligonucleotide constructs.
Mitsubishi Tanabe has announced plans to transfer its fine-chemical operations to two companies and withdraw from the fine-chemical industry.
Piramal Healthcare has agreed to acquire Decision Resources Group, a healthcare information management company, for approximately $635 million.
Shimadzu has added a triple quadrupole gas chromatograph mass spectrometer and has also expanded its LC–MS/MS product portfolio.
People News
AMRI has appointed Ian Shott as president of AMRI Europe.
BASi has named David Reynolds as its director of discovery systems.
Camargo has appointed K. Gary Barnette as vice-president of drug development.
Teva’s board of directors has voted to re-elect Phillip Frost as chairman of the board.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.